313 related articles for article (PubMed ID: 29427356)
1. Epidemiology and outcomes of Clostridium difficile infection in allogeneic hematopoietic cell and lung transplant recipients.
Dubberke ER; Reske KA; Olsen MA; Bommarito K; Cleveland AA; Silveira FP; Schuster MG; Kauffman CA; Avery RK; Pappas PG; Chiller TM
Transpl Infect Dis; 2018 Apr; 20(2):e12855. PubMed ID: 29427356
[TBL] [Abstract][Full Text] [Related]
2. Early Clostridioides difficile infection characterizations, risks, and outcomes in allogeneic hematopoietic stem cell and solid organ transplant recipients.
Obeid KM; Sapkota S; Cao Q; Richmond S; Watson AP; Karadag FK; Young JH; Pruett T; Weisdorf DJ; Ustun C
Transpl Infect Dis; 2022 Feb; 24(1):e13720. PubMed ID: 34455662
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology, risk factors, and outcome of Clostridium difficile infection in heart and heart-lung transplant recipients.
Bruminhent J; Cawcutt KA; Thongprayoon C; Petterson TM; Kremers WK; Razonable RR
Clin Transplant; 2017 Jun; 31(6):. PubMed ID: 28314071
[TBL] [Abstract][Full Text] [Related]
4. Risk factors and epidemiology of Clostridium difficile infection in hematopoietic stem cell transplant recipients during the peritransplant period.
Aldrete SD; Kraft CS; Magee MJ; Chan A; Hutcherson D; Langston AA; Greenwell BI; Burd EM; Friedman-Moraco R
Transpl Infect Dis; 2017 Feb; 19(1):. PubMed ID: 27943501
[TBL] [Abstract][Full Text] [Related]
5. Risk for
Dubberke ER; Reske KA; Olsen MA; Bommarito KM; Seiler S; Silveira FP; Chiller TM; DiPersio J; Fraser VJ
Transplant Direct; 2017 Apr; 3(4):e145. PubMed ID: 28405601
[TBL] [Abstract][Full Text] [Related]
6. Clostridioides difficile infection in solid organ and hematopoietic stem cell transplant recipients: A prospective multinational study.
Blumberg EA; Collins G; Young JH; Nguyen MH; Michonneau D; Temesgen Z; Origȕen J; Barcan L; Obeid KM; Belloso WH; Gras J; Corbelli GM; Neaton JD; Lundgren J; Snydman DR; Molina JM;
Transpl Infect Dis; 2022 Feb; 24(1):e13770. PubMed ID: 34821423
[TBL] [Abstract][Full Text] [Related]
7. Evaluating risk factors for Clostridium difficile infection in adult and pediatric hematopoietic cell transplant recipients.
Boyle NM; Magaret A; Stednick Z; Morrison A; Butler-Wu S; Zerr D; Rogers K; Podczervinski S; Cheng A; Wald A; Pergam SA
Antimicrob Resist Infect Control; 2015; 4():41. PubMed ID: 26473030
[TBL] [Abstract][Full Text] [Related]
8. Postoperative antimicrobials after lung transplantation and the development of multidrug-resistant bacterial and Clostridium difficile infections: an analysis of 500 non-cystic fibrosis lung transplant patients.
Whiddon AR; Dawson KL; Fuentes A; Perez KK; Peterson LE; Kaleekal T
Clin Transplant; 2016 Jul; 30(7):767-73. PubMed ID: 27091109
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for the development of Clostridium difficile infection in adult allogeneic hematopoietic stem cell transplant recipients: A single-center study in Québec, Canada.
Lavallée C; Labbé AC; Talbot JD; Alonso CD; Marr KA; Cohen S; Laverdière M; Dufresne SF
Transpl Infect Dis; 2017 Feb; 19(1):. PubMed ID: 27943498
[TBL] [Abstract][Full Text] [Related]
10. Clostridium difficile infection, a descriptive analysis of solid organ transplant recipients at a single center.
Tsapepas DS; Martin ST; Miao J; Shah SA; Scheffert J; Fester K; Ma K; Lat A; Egan R; McKeen JT
Diagn Microbiol Infect Dis; 2015 Apr; 81(4):299-304. PubMed ID: 25586932
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for recurrent Clostridium difficile infection in allogeneic hematopoietic cell transplant recipients.
Mani S; Rybicki L; Jagadeesh D; Mossad SB
Bone Marrow Transplant; 2016 May; 51(5):713-7. PubMed ID: 26726944
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology and outcomes of Clostridium difficile infections in hematopoietic stem cell transplant recipients.
Alonso CD; Treadway SB; Hanna DB; Huff CA; Neofytos D; Carroll KC; Marr KA
Clin Infect Dis; 2012 Apr; 54(8):1053-63. PubMed ID: 22412059
[TBL] [Abstract][Full Text] [Related]
13. A multicenter study to define the epidemiology and outcomes of Clostridioides difficile infection in pediatric hematopoietic cell and solid organ transplant recipients.
Mayer EF; Maron G; Dallas RH; Ferrolino J; Tang L; Sun Y; Danziger-Isakov L; Paulsen GC; Fisher BT; Vora SB; Englund J; Steinbach WJ; Michaels M; Green M; Yeganeh N; Gibson JE; Dominguez SR; Nicholson MR; Dulek DE; Ardura MI; Rajan S; Gonzalez BE; Beneri C; Herold BC
Am J Transplant; 2020 Aug; 20(8):2133-2142. PubMed ID: 32064754
[TBL] [Abstract][Full Text] [Related]
14. Clostridium difficile infection in the hematopoietic unit: a meta-analysis of published studies.
Zacharioudakis IM; Ziakas PD; Mylonakis E
Biol Blood Marrow Transplant; 2014 Oct; 20(10):1650-4. PubMed ID: 24914822
[TBL] [Abstract][Full Text] [Related]
15. Oral Vancomycin Prophylaxis Is Highly Effective in Preventing Clostridium difficile Infection in Allogeneic Hematopoietic Cell Transplant Recipients.
Ganetsky A; Han JH; Hughes ME; Babushok DV; Frey NV; Gill SI; Hexner EO; Loren AW; Luger SM; Mangan JK; Martin ME; Smith J; Freyer CW; Gilmar C; Schuster M; Stadtmauer EA; Porter DL
Clin Infect Dis; 2019 May; 68(12):2003-2009. PubMed ID: 30256954
[TBL] [Abstract][Full Text] [Related]
16. Clostridium difficile infection after allogeneic hematopoietic stem cell transplantation: incidence, risk factors, and outcome.
Willems L; Porcher R; Lafaurie M; Casin I; Robin M; Xhaard A; Andreoli AL; Rodriguez-Otero P; Dhedin N; Socié G; Ribaud P; Peffault de Latour R
Biol Blood Marrow Transplant; 2012 Aug; 18(8):1295-301. PubMed ID: 22387347
[TBL] [Abstract][Full Text] [Related]
17. Clostridium difficile infection increases mortality risk in lung transplant recipients.
Lee JT; Kelly RF; Hertz MI; Dunitz JM; Shumway SJ
J Heart Lung Transplant; 2013 Oct; 32(10):1020-6. PubMed ID: 23891145
[TBL] [Abstract][Full Text] [Related]
18. Retrospective evaluation of fidaxomicin versus oral vancomycin for treatment of Clostridium difficile infections in allogeneic stem cell transplant.
Prohaska L; Mahmoudjafari Z; Shune L; Singh A; Lin T; Abhyankar S; Ganguly S; Grauer D; McGuirk J; Clough L
Hematol Oncol Stem Cell Ther; 2018 Dec; 11(4):233-240. PubMed ID: 29928848
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology, Risk Factors, and Outcomes After Early Posttransplant
Jorgenson MR; Descourouez JL; Yang DY; Leverson GE; Saddler CM; Smith JA; Safdar N; Mandlebrot DA; Redfield RR
Ann Pharmacother; 2019 Oct; 53(10):1020-1025. PubMed ID: 31007034
[TBL] [Abstract][Full Text] [Related]
20. Clostridium difficile infection after allogeneic hematopoietic stem cell transplant: strain diversity and outcomes associated with NAP1/027.
Kamboj M; Xiao K; Kaltsas A; Huang YT; Sun J; Chung D; Wu S; Sheahan A; Sepkowitz K; Jakubowski AA; Papanicolaou G
Biol Blood Marrow Transplant; 2014 Oct; 20(10):1626-33. PubMed ID: 24973628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
